XML 24 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares and Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Loss, Net of Tax
Non-controlling Interests
Beginning Balance (in shares) at Dec. 31, 2019   232.1      
Beginning Balance at Dec. 31, 2019 $ 3,443 $ 6,154 $ 1,248 $ (4,033) $ 74
Increase (Decrease) in Shareholders' Equity          
Net income 2,018   1,969   49
Shares issued — employee stock compensation plans (in shares)   1.9      
Shares issued — employee stock compensation plans (154) $ (154)      
Shares repurchased (in shares)   (8.5)      
Shares repurchased (1,763)   (1,763)    
Share-based compensation expense 317 $ 317      
Dividends to shareholders (412)   (412)    
Net change in fair value of financial instruments 13     13  
Net foreign currency translation adjustments 263     260 3
Net postretirement benefit obligation (101)     (101)  
Net purchases of shares from noncontrolling interests (9) $ (3)     (6)
Dividends paid to noncontrolling interests on subsidiary common stock (32)       (32)
Ending Balance (in shares) at Dec. 31, 2020   225.5      
Ending Balance at Dec. 31, 2020 3,583 $ 6,314 1,042 (3,861) 88
Increase (Decrease) in Shareholders' Equity          
Net income 1,308   1,255   53
Shares issued — employee stock compensation plans (in shares)   1.7      
Shares issued — employee stock compensation plans (130) $ (129) (1)    
Shares repurchased (in shares)   (12.4)      
Shares repurchased (3,543)   (3,543)    
Share-based compensation expense 449 $ 449      
Dividends to shareholders (447)   (447)    
Net change in fair value of financial instruments 1     1  
Net foreign currency translation adjustments (289)     (288) (1)
Net postretirement benefit obligation 277     277  
Net purchases of shares from noncontrolling interests (13) $ (8)     (5)
Dividends paid to noncontrolling interests on subsidiary common stock $ (38)       (38)
Ending Balance (in shares) at Dec. 31, 2021 214.8 214.8      
Ending Balance at Dec. 31, 2021 $ 1,158 $ 6,626 (1,694) (3,871) 97
Increase (Decrease) in Shareholders' Equity          
Net income 2,646   2,589   57
Shares issued — employee stock compensation plans (in shares)   1.7      
Shares issued — employee stock compensation plans (157) $ (156) (1)    
Shares repurchased (in shares)   (11.1)      
Shares repurchased (3,203)   (3,203)    
Share-based compensation expense 397 $ 397      
Dividends to shareholders (463)   (463)    
Net change in fair value of financial instruments (13)     (13)  
Net foreign currency translation adjustments (528)     (528) 0
Net postretirement benefit obligation (211)     (211)  
Net purchases of shares from noncontrolling interests (2) $ (1)     (1)
Dividends paid to noncontrolling interests on subsidiary common stock $ (53)       (53)
Ending Balance (in shares) at Dec. 31, 2022 205.4 205.4      
Ending Balance at Dec. 31, 2022 $ (429) $ 6,866 $ (2,772) $ (4,623) $ 100